ArticleBio-protocol2026
RNA Detection Technologies: A MethodCentric Guide to Principles and Reproducibility.
Article in Bio-protocol, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
RNA detection techniques have expanded into a diverse methodological landscape spanning hybridization, amplification, imaging, and sequencing. In this review, we provide a methodcentric synthesis of the major technologies that define this landscape, emphasizing how each method's core principle, practical strengths, and sources of variability shape its reproducibility. Beginning with foundational approaches, we trace the development of isothermal amplification, quantitative and digital PCR, microarrays, singlemolecule imaging, multiplexed spatial methods, and amplificationfree digital quantification. We then examine the transformative impact of bulk, singlecell, longread, directRNA, and spatial transcriptomics, as well as CRISPRbased detection and metabolic labeling for RNA dynamics. Across these technologies, we focus on reproducibility as a defining dimension of evaluation: mature methods benefit from established standards, whereas newer approaches remain prestandardization and require careful, experimentspecific controls. Rigorous method selection must be guided by the biological question, required resolution, sample constraints, and the maturity of each method's reproducibility framework. We conclude that RNA detection methods form interconnected methodological paths of problemsolving rather than simple replacements.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.